Skip to main content
Premium Trial:

Request an Annual Quote

Applied Biosystem’s TaqMan OpenArray Genotyping System

Premium
Applied Biosystems announced this week the launch of the TaqMan OpenArray Genotyping System, a new analysis platform that allows researchers to perform faster and more cost-effective high-sample-throughput genotyping studies, the company said.
 
“This system expands the potential uses of TaqMan technology across a wide range of genotyping applications, providing an extremely fast, high-sample-throughput validation and screening tool for researchers in agricultural, pharmaceutical, and other commercial industries, as well as academic institutions,” ABI said in a statement.
 
Using this platform, which was developed as part of a collaboration between ABI and BioTrove, researchers can analyze “thousands to tens of thousands of samples in days, in contrast to weeks or months on alternative genotyping platforms.”
 
Researchers can use this platform to associate genotypes with complex diseases, ethnic ancestry, drug response, as well as traits for breeding and quality control in agricultural studies. 
 
ABI holds the exclusive rights to develop and market custom-built OpenArray plates of TaqMan SNP Genotyping Assays.

Filed under

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.